These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11517408)

  • 1. A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: implications for prophylactic and therapeutic treatment of progressive multifocal leukencephalopathy.
    Atwood WJ
    J Neurovirol; 2001 Aug; 7(4):307-10. PubMed ID: 11517408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy.
    Baum S; Ashok A; Gee G; Dimitrova S; Querbes W; Jordan J; Atwood WJ
    J Neurovirol; 2003; 9 Suppl 1():32-7. PubMed ID: 12709869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the role of cytokine activation in the multiplication of JC virus (JCV) in human fetal glial cells.
    Atwood WJ; Wang L; Durham LC; Amemiya K; Traub RG; Major EO
    J Neurovirol; 1995 Mar; 1(1):40-9. PubMed ID: 9222341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis.
    Pho MT; Ashok A; Atwood WJ
    J Virol; 2000 Mar; 74(5):2288-92. PubMed ID: 10666259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab.
    Uleri E; Ibba G; Piu C; Caocci M; Leoni S; Arru G; Serra C; Sechi G; Dolei A
    J Neurovirol; 2017 Apr; 23(2):226-238. PubMed ID: 27812788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy.
    Co JK; Verma S; Gurjav U; Sumibcay L; Nerurkar VR
    J Infect Dis; 2007 Sep; 196(5):712-8. PubMed ID: 17674314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
    Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology of progressive multifocal leukoencephalopathy.
    Jelcic I; Jelcic I; Faigle W; Sospedra M; Martin R
    J Neurovirol; 2015 Dec; 21(6):614-22. PubMed ID: 25740538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
    Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M
    J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cell culture-grown JC virus (primary human fetal glial cells and the JCI cell line) and recombinant JCV VP1 as antigen for the detection of anti-JCV antibody by haemagglutination inhibition.
    Knowles WA; Sasnauskas K
    J Virol Methods; 2003 Apr; 109(1):47-54. PubMed ID: 12668267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of mefloquine efficacy against JC virus in vitro.
    Brickelmaier M; Lugovskoy A; Kartikeyan R; Reviriego-Mendoza MM; Allaire N; Simon K; Frisque RJ; Gorelik L
    Antimicrob Agents Chemother; 2009 May; 53(5):1840-9. PubMed ID: 19258267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host.
    Hou J; Major EO
    J Neurovirol; 2000 May; 6 Suppl 2():S98-S100. PubMed ID: 10871795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the soluble factors secreted by activated immune cells suppress replication of human neurotropic JC virus DNA in glial cells.
    Chang CF; Otte J; Kerr DA; Välkkilä M; Calkins CE; Khalili K
    Virology; 1996 Jul; 221(1):226-31. PubMed ID: 8661431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray analysis of glial cells resistant to JCV infection suggests a correlation between viral infection and inflammatory cytokine gene expression.
    Manley K; Gee GV; Simkevich CP; Sedivy JM; Atwood WJ
    Virology; 2007 Sep; 366(2):394-404. PubMed ID: 17555786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology and immunoregulation of human neurotropic JC virus in CNS.
    Sweet TM; Del Valle L; Khalili K
    J Cell Physiol; 2002 Jun; 191(3):249-56. PubMed ID: 12012320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interplay between T-Antigen and splicing factor, arginine/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells.
    Craigie M; Regan P; Otalora YL; Sariyer IK
    Virol J; 2015 Nov; 12():196. PubMed ID: 26596376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of JC virus in two African cases of progressive multifocal leukoencephalopathy including identification of JCV type 3 in a Gambian AIDS patient.
    Stoner GL; Agostini HT; Ryschkewitsch CF; Mazló M; Gullotta F; Wamukota W; Lucas S
    J Med Microbiol; 1998 Aug; 47(8):733-42. PubMed ID: 9877195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyomavirus JC in the context of immunosuppression: a series of adaptive, DNA replication-driven recombination events in the development of progressive multifocal leukoencephalopathy.
    Johnson EM; Wortman MJ; Dagdanova AV; Lundberg PS; Daniel DC
    Clin Dev Immunol; 2013; 2013():197807. PubMed ID: 23690820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propagation of archetype and nonarchetype JC virus variants in human fetal brain cultures: demonstration of interference activity by archetype JC virus.
    O'Neill FJ; Greenlee JE; Dörries K; Clawson SA; Carney H
    J Neurovirol; 2003 Oct; 9(5):567-76. PubMed ID: 13129771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy.
    Seth P; Diaz F; Major EO
    J Neurovirol; 2003 Apr; 9(2):236-46. PubMed ID: 12707854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.